𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status

✍ Scribed by Angela M. Tutera; Thomas A. Sellers; John D. Potter; Carol R. Drinkard; Georgia L. Wiesner; Aaron R. Folsom


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
906 KB
Volume
13
Category
Article
ISSN
0741-0395

No coin nor oath required. For personal study only.

✦ Synopsis


There are recent data to suggest that risk factors for breast cancer may differ according to whether the tumor expresses detectable levels of the estrogen receptor (ER) and progesterone receptor (PR). While a family history of breast cancer is one of the most consistent predictors of the disease, we recently reported a modest inverse association with ER+PRtumors. However, the definition of a family history of cancer did not consider second-degree relatives or cancer sites that may be etiologically related. The current report presents additional data analysis from the Iowa Women's Health Study, a prospective population-based cohort study conducted among 41,837 postmenopausal women. At baseline in 1986, respondents provided information on family history of cancers of the breast, ovaries, or uterus/endometrium in their mothers, sisters, daughters, maternal and paternal grandmothers, and maternal and paternal aunts. Data on family history of prostate cancer in fathers and brothers and age at onset of breast cancer in mothers and sisters were collected in 1992. Cohort members were followed for cancer incidence through the statewide tumor registry. After 7 years and more than 235,000 personyears of follow-up, 939 incident cases of breast cancer were identified. Information was obtained from the tumor registry on ER (+/-) and PR (+/-) status for 610 cases (65.0%). A family history of breast cancer in first-degree relatives was asso-


πŸ“œ SIMILAR VOLUMES


Body weight and incidence of breast canc
✍ Reiko Suzuki; Nicola Orsini; Shigehira Saji; Timothy J. Key; Alicja Wolk πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 344 KB πŸ‘ 2 views

## Abstract Epidemiological evidence indicates that the association between body weight and breast cancer risk may differ across menopausal status as well as the estrogen receptor (ER) and progesterone receptor (PR) tumor status. To date, no meta‐analysis has been conducted to assess the associatio

Alcohol intake and risk of breast cancer
✍ Reiko Suzuki; Nicola Orsini; Laura Mignone; Shigehira Saji; Alicja Wolk πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 163 KB πŸ‘ 2 views

## Abstract The association between alcohol consumption and an increased risk of breast cancer has been established. It is still unclear however, whether this relationship differs across the estrogen receptor (ER) and progesterone receptor (PR) tumors subtypes. To provide a quantitative assessment

Serum enterolactone and postmenopausal b
✍ Aida Karina Zaineddin; Alina Vrieling; Katharina Buck; Susen Becker; Jakob Linse πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 381 KB

## Abstract Lignans are a group of estrogenic compounds present in plants. Several epidemiological studies proposed that lignans may protect against breast cancer by exerting anticarcinogenic activity. Levels of enterolactone were determined in serum samples of 1,250 cases and 2,164 controls from a

Body weight and postmenopausal breast ca
✍ Reiko Suzuki; Tove Rylander-Rudqvist; Weimin Ye; Shigehira Saji; Alicja Wolk πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 112 KB πŸ‘ 2 views

## Abstract Although obesity is one of the established risk factors for postmenopausal breast cancer, it is not clear whether this positive association differs across estrogen receptor (ER) and progesterone receptor (PR) status of breast tumors. We evaluated the association between body weight and